Abstract
Huntington′s disease (HD) is a neurodegenerative genetic condition for which a predictive genetic test by mutation analysis has been available since 1993. However, whilst revealing the future presence of the disease, testing may have an adverse psychological impact given that the disease is progressive, incurable and ultimately fatal. This review seeks to systematically explore the psychological impact of genetic testing for individuals undergoing pre-symptomatic mutation analysis. Three databases (Medline, PsycInfo and Scopus) were interrogated for studies utilising standardised measures to assess psychological impact following predictive genetic testing for HD. From 100 papers initially identified, eight articles were eligible for inclusion. Psychological impact of predictive genetic testing was not found to be associated with test result. No detrimental effect of predictive genetic testing on non-carriers was found, although the process was not found to be psychologically neutral. Fluctuation in levels of distress was found over time for carriers and non-carriers alike. Methodological weaknesses of published literature were identified, notably the needs of individuals not requesting genetic testing, as well as inadequate support for individuals registering elevated distress and declining post-test follow-up. Further assessment of these vulnerable individuals is warranted to establish the extent and type of future psychological support.
Similar content being viewed by others
References
Adam, S., Wiggins, S., Lawson, K., McKellin, B. & Hayden, M. (1995). Predictive testing for Huntington disease (HD): Differences in uptake and characteristics of linked marker and direct test cohorts. American Journal of Human Genetics: 57(suppl.), A292
Almqvist, E. W., Brinkman, R. R., Wiggins, S., & Hayden, M. R. (2003). Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington′s disease. Clinical Genetics, 64, 300–309.
Arran, N., Craufurd, D., & Simpson, J. (2014). Illness perceptions, coping styles and psychological distress in adults with Huntington′s disease. Psychology, Health & Medicine, 19, 169–179.
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.
Beck, A. T. (1974). The measurement of pessimism: The hopelessness scale. Journal of Consulting and Clinical Psychology, 42, 861–865.
Bisson, J. I., Jenkins, P. L., Alexander, J., & Bannister, C. (1997). Randomised controlled trial of psychological debriefing for victims of acute burn trauma. British Journal of Psychiatry, 171, 78–81.
Broadstock, M., Michie, S., & Marteau, T. M. (2000). The psychological consequences of predictive genetic testing: A systematic review. European Journal of Human Genetics, 8, 731–738.
Bullinger, M., & Kirchberger, I. (1998). SF-36: Fragebogen zum Gesundheitszustand. Göttingen: Hogrefe.
Codori, A., Slavney, P. R., Young, C., Miglioretti, D. L., & Brandt, J. (1997). Predictors of psychological adjustment to genetic testing for Huntington′s disease. Health Psychology, 16, 36–50.
Craufurd, D., Dodge, A., Kerzin-Storrar, L., & Harris, R. (1989). Uptake of presymptomatic predictive testing for Huntington′s disease. Lancet, 334, 603–605.
Da Costa, B. R., Cevallos, M., Altman, D. G., Rutjes, A. W. S., & Egger, M. (2011). Uses and misuses of the STROBE statement: Bibliographic study. BMJ Open, 1, e000048.
Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., Demyttenaere, K., et al. (1996). Prediction of psychological functioning one year after the predictive test for Huntington′s disease and impact of the test result on reproductive decision making. Journal of Medical Genetics, 33, 737–743.
Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cloostermans, T., Cassiman, J., Demyttenaere, K., et al. (1997). Non-participation in predictive testing for Huntington disease: Individual decision-making, personality and avoidant behavior in the family. European Journal of Human Genetics, 5, 351–363.
Derogatis, L., & Melisaratos, N. (1983). The brief symptom inventory: An introductory report. Psychological Medicine, 13, 595–605.
Dudok DeWit, A. C., Tibben, A., Duivenoorden, H. J., Frets, P. G., Zoeteweij, M. W., Losekoot, M., et al. (1997). Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. Journal of Medical Genetics, 34, 382–390.
Dudok DeWit, A. C., Duivenvoorden, H. J., Passchier, J., Niermeijer, M. F., & Tibben, A. (1998). Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: An explorative study. Psychosomatic Medicine, 60, 543–549.
Duncan, R. E., Gillam, L., Savulescu, J., Williamson, R., Rogers, J. G., & Delatycki, M. B. (2008). “You’re one of us now”: Young people describe their experience of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 148C, 47–55.
Evers-Kiebooms, G., & Decruyenaere, M. (1998). Predictive testing for Huntington′s disease: A challenge for persons at risk and for professionals. Patient Education and Counseling, 35, 15–26.
Fanos, J. H., & Johnson, J. P. (1995). Barriers to carrier testing for adult cystic fibrosis sibs: The importance of not knowing. American Journal of Medical Genetics, 59, 85–91.
Folstein, S. E. (1989). Huntington′s Disease: A Disorder of Families. Baltimore, MD: John Hopkins University Press.
Fox, S., Bloch, M., Fahy, M., & Hayden, M. R. (1989). Predictive testing for Huntington′s disease: I Description of a pilot project in British Columbia. American Journal of Medical Genetics Part A, 32, 211–216.
Gargiulo, M., Lejeune, S., Tanguy, M. L., Lahlou-Laforêt, K., Faudet, A., Cohen, D., et al. (2009). Long-term outcome of presymptomatic testing in Huntington disease. European Journal of Human Genetics, 17, 165–171.
Geller, G., & Holtzman, N. A. (1995). A qualitative assessment of primary care physicians’ perceptions about the ethical and social implications of offering genetic testing. Qualitative Health Research, 5, 97–116.
Goldberg, D., & Williams, P. (1988). A User′s Guide to the General Health Questionnaire. Nfer-Nelson: Windsor.
Gooding, H. C., Organista, K., Burack, J., & Bowles Biesecker, B. (2006). Genetic susceptibility testing from a stress and coping perspective. Social Science & Medicine, 62, 1880–1890.
Graham, J. R. (1987). The MMPI: A practical guide. New York: Oxford University Press.
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., et al. (1983). A polymorphic DNA marker genetically linked to Huntington′s disease. Nature, 306, 234–238.
Hagberg, A., Winnberg, E., & Bui, T. H. (2011). More appreciation of life or regretting the test? Experiences of living as a mutation carrier of Huntington′s disease. Journal of Genetic Counseling, 20, 70–79.
Hayden, M. R., & Bombard, Y. (2005). Psychosocial effects of predictive testing for Huntington′s disease. Advances in Neurology, 96, 226–239.
Hobbs, M., Mayou, R., Harrison, B., & Worlock, P. (1996). A randomised controlled trial of psychological debriefing for victims of road traffic accidents. British Medical Journal, 313, 1438–1439.
Hocaoglu, M. B., Gaffan, E. A., & Ho, A. K. (2012). The Huntington′s disease health-related quality of life questionnaire (HDQoL): A disease specific measure of health-related quality of life. Clinical Genetics, 81, 117–122.
Horowitz, M. J., Wilner, N., & Alvarez, W. (1979). Impact of events scale: A measure of subjective stress. Psychosomatic Medicine, 41, 209–218.
Horowitz, M. J., Field, N. P., Zanko, A., Donnelly, E. F., Epstein, C., & Longo, F. (2001). Psychological impact of news of genetic risk for Huntington disease. American Journal of Medical Genetics, 103, 188–192.
Huggins, M., Bloch, M., Wiggins, S., Adam, S., Suchowersky, O., Trew, M., et al. (1992). Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk. American Journal of Medical Genetics, 42, 508–515.
Huntington Study Group. (1996). Unified Huntington′s disease rating scale: Reliability and consistency. Movement Disorders, 11(2), 136–142.
Huntington′s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington′s disease chromosomes. Cell, 72, 971–983.
Huntington′s Disease Society of America (2001). Genetic testing for Huntington′s disease: Its relevance and implications (Revised. Retrieved November 2013 from: https://doi.org/www.hdsa.org/images/content/1/1/11884.pdf
Huntington, G. (1872). On chorea. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 109–112.
International Huntington Association and the World Federation of Neurology Research Group on Huntington′s Chorea. (1994). Guidelines for the molecular genetics predictive test in Huntington′s disease. Journal of Medical Genetics, 31, 557–559.
Janoff-Bulman, R. (1992). Shattered Assumptions: Towards a New Psychology of Trauma. New York: The Free Press.
Kessler, S. (1987). Psychiatric implications of presymptomatic testing for Huntington′s disease. American Journal of Orthopsychiatry, 57, 212–219.
Kessler, S., Field, T., & Worth, L. (1987). Attitudes of persons at risk for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk. American Journal of Medical Genetics, 26, 259–270.
Kessler, S. (1994). Predictive testing for Huntington′s disease: A psychologist′s view. American Journal of Medical Genetics, 54, 161–166.
Koller, W. E., & Davenport, J. (1984). Genetic testing in Huntington′s disease. Annals of Neurology, 16, 511–513.
Konrad, M. (2003). Predictive genetic testing and the making of the pre-symptomatic person: Prognostic moralities amongst Huntington′s affected families. Anthropology & Medicine, 10, 23–49.
Larsson, M. U., Luszez, M. A., Bui, T. H., & Wahlin, T. B. R. (2006). Depression and suicidal ideation after predictive testing for Huntington′s disease: A two-year follow up study. Journal of Genetic Counseling, 15, 361–374.
Leventhal, H., Leventhal, E. A., & Contrada, R. J. (1998). Self regulation, health and behavior: A perceptual-cognitive approach. Psychology & Health, 13, 717–733.
Leventhal, H., Leventhal, E. A. & Cameron, L. (2001). Representations, procedures, and affect in illness self-regulation: A perceptual-cognitive model. In A. Baum, T. A. Revenson & J. E. Singer (Eds.). Handbook of Health Psychology. Lawrence Erlbaum Associates: Mahwah, NJ. pp. 19–47
Licklederer, C., Wolff, G., & Barth, J. (2008). Mental health and quality of life after genetic testing for Huntington disease: A long term effect study in Germany. American Journal of Medical Genetics. Part A, 146, 2078–2085.
MacLeod, R., Tibben, A., Frontali, M., Evers-Kiebooms, G., Martinex-Descales, A., Roos, R. A., et al. (2012). Recommendations for the predictive genetic test in Huntington′s disease. Clinical Genetics, 83, 221–231.
McNally, R. J., Bryant, R. A., & Bryant, A. (2003). Does early psychological intervention promote recovery from posttraumatic stress? Psychological Science in the Public Interest:, 4, 45–79.
Meiser, B., & Dunn, S. (2000). Psychological impact of genetic testing for Huntington′s disease: An update of the literature. Journal of Neurology, Neurosurgery & Psychiatry, 69, 574–578.
Michie, S., Bobrow, M., & Marteau, T. M. (2001). Predictive genetic testing in children and adults: A study of emotional impact. Journal of Medical Genetics, 38, 519–526.
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta analyses: The prisma statement. PLoS Medicine, 6, e1000097.
Myers, R. H. (2004). Huntington′s disease genetics. Journal of the American Society for Experimental Neurotherapeutics:, 1, 255–262.
O′Rourke, J. J. F. (2011). Posttraumatic growth in Huntington disease: Measuring the effects of genetic testing and disease on positive psychological change. Unpublished PhD thesis, University of Iowa
Patrick, D. L. & Deyo, R. A. (1989). Generic and disease-specific measures in assessing health status and quality of life. Medical Care: 27 (supplement 3), S217-32
Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012). The incidence and prevalence of Huntington′s disease: A systematic review and meta-analysis. Movement Disorders, 27, 1083–1091.
Quaid, K. A., & Morris, M. (1993). Reluctance to undergo predictive testing: The case of Huntington disease. American Journal of Medical Genetics, 45, 41–45.
Rolland, J. S. (1984). Toward a psychosocial typology of chronic and life-threatening illness. Family Systems Medicine:, 2, 245–263.
Rolland, J. S., & Williams, J. K. (2005). Toward a biopsychosocial model for 21st century genetics. Family Process, 44, 3–24.
Rozema, H., Völlink, T., & Lechner, L. (2009). The role of illness representations in coping and health of patients treated for breast cancer. Psycho-Oncology, 18, 849–857.
Salkovskis, P. M., & Rimes, K. A. (1997). Predictive genetic testing: Psychological factors. Journal of Psychosomatic Research, 43, 477–487.
Schwartz, R. R. (2010). Ripples from a stone skipping across the lake: A narrative approach to the meaning of Huntington′s disease. Journal of Neuroscience Nursing, 42, 157–168.
Senior, V., Marteau, T. M., & Peters, T. P. (1999). Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. Social Science & Medicine, 48, 1857–1860.
Sobel, S. K., & Cowen, D. B. (2000). Impact of genetic testing for Huntington disease on the family system. American Journal of Medical Genetics, 90, 49–59.
Spielberger, C. D. (1983). State Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
Snell, W. E., Johnson, G., Lloyd, P. J., & Hoover, M. W. (1991). The health orientation scale: A measure of psychological tendencies associated with health. European Journal of Personality, 5, 169–183.
Tedeschi, R. G., & Calhoun, L. G. (2004). Posttraumatic growth: Conceptual foundations and empirical evidence. Psychological Inquiry, 15, 1–18.
Timman, R., Roos, R., Maat-Kievit, A., & Tibben, A. (2004). Adverse effects of predictive testing for Huntington disease underestimated: Long-term effects 7–10 years after the test. Health Psychology, 23, 189–197.
Tyler, A., & Harper, P. S. (1983). Attitudes of subjects at risk and their relatives towards genetic counseling in Huntington′s chorea. Journal of Medical Genetics, 20, 179–188.
Van Der Steenstraten, I. M., Tibben, A., Roos, R. A. C., Van De Kamp, J. J. P., & Niermeijer, M. F. (1994). Predictive testing for Huntington disease: Nonparticipants compared with participants in the Dutch program. American Journal of Human Genetics, 55, 618–625.
Von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbrouche, J. P. (2008). The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Journal of Clinical Epidemiology, 61, 344–349.
Wahlin, T. B. R., Bäckman, L., Lundin, A., Haegermark, A., Winblad, B., & Anvret, M. (2000). High suicidal ideation in persons testing for Huntington′s disease. Acta Neurologica Scandinavica, 102, 150–161.
Witjes-Ané, M. N. W., Zwinderman, A. H., Tibben, A., Van Ommen, G. J. B., & Roos, R. A. C. (2002). Behavioural complaints in participants who underwent predictive testing for Huntington′s disease. Journal of Medical Genetics, 39, 857–862.
Zebrack, B. J., Ganz, P. A., Bernaards, C. A., Petersen, L., & Abraham, L. (2006). Assessing the impact of cancer: Development of a new instrument for long-term survivors. Psycho-Oncology, 15, 407–421.
Zebrack, B. J., Yi, J., Petersen, L., & Ganz, P. A. (2008). The impact of cancer and quality of life for long-term survivors. Psycho-Oncology, 17, 891–900.
Conflict of Interest Statement
S Crozier, N Robertson and M Dale declare that they have no conflict of interest.
Human Studies and Informed Consent
No human studies were carried out by the authors for this article.
Animal Studies
No animal or human studies were carried out by the authors for this article.
Author information
Authors and Affiliations
Corresponding author
Additional information
This manuscript is submitted solely to this journal and was not published elsewhere.
Rights and permissions
About this article
Cite this article
Crozier, S., Robertson, N. & Dale, M. The Psychological Impact of Predictive Genetic Testing for Huntington′s Disease: A Systematic Review of the Literature. J Genet Counsel 24, 29–39 (2015). https://doi.org/10.1007/s10897-014-9755-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-014-9755-y